Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
United Therapeutics Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +650 | — | — |
| Apr 24, 2026 | United Therapeutics Corporation | Option exercise | +2,910 | $101.80 | $296,238 |
| Apr 24, 2026 | United Therapeutics Corporation | Open-market sale | −2,910 | $569.00 | $1,655,790 |
| Apr 17, 2026 | United Therapeutics Corporation | Option exercise | +1,000 | $101.80 | $101,800 |
| Apr 17, 2026 | United Therapeutics Corporation | Open-market sale | −1,000 | $578.88 | $578,880 |
| Dec 15, 2025 | United Therapeutics Corporation | Option exercise | +1,000 | $101.80 | $101,800 |
| Dec 15, 2025 | United Therapeutics Corporation | Open-market sale | −1,000 | $495.95 | $495,950 |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +590 | — | — |
| Mar 19, 2025 | United Therapeutics Corporation | Option exercise | +5,000 | $175.43 | $877,150 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −300 | $307.73 | $92,319 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −1,780 | $308.82 | $549,700 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −328 | $309.73 | $101,591 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −457 | $310.80 | $142,036 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −736 | $312.22 | $229,794 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −1,299 | $313.14 | $406,769 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.